statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Scinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and Appeal Scinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and Appeal PR Newswire JERUSALEM...

Scinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and Appeal

Scinai to showcase its novel biological local therapeutic for Plaque Psoriasis at Dermatology Drug Development Summit together with Prof. Michael Schn of UMG Scinai to showcase its novel biological...

Scinai to showcase its novel biological local therapeutic for Plaque Psoriasis at Dermatology Drug Development Summit together with Prof. Michael Schn of UMG

Scinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug Development and cGMP Manufacturing Services Scinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug...

Scinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug Development and cGMP Manufacturing Services

Scinai leadership to attend BIO-Europe Spring 2024 Scinai leadership to attend BIO-Europe Spring 2024 PR Newswire JERUSALEM, March 12, 2024 Showcasing Company's cGMP biologics CDMO and innovative...

Scinai leadership to attend BIO-Europe Spring 2024

Scinai to showcase its cGMP biologics CDMO and innovative NanoAb pipeline at MIXiii 2024 Scinai to showcase its cGMP biologics CDMO and innovative NanoAb pipeline at MIXiii 2024 PR Newswire...

Scinai to showcase its cGMP biologics CDMO and innovative NanoAb pipeline at MIXiii 2024

Scinai Welcomes Liat Halpert as Head of Business Development and Sales Scinai Welcomes Liat Halpert as Head of Business Development and Sales PR Newswire JERUSALEM, Feb. 13, 2024 JERUSALEM, Feb. 13...

Scinai Welcomes Liat Halpert as Head of Business Development and Sales

Scinai Immunotherapeutics Congratulates its Co-Lead Scientific Research Collaborator Dirk Grlich on Louis-Jeantet Prize Scinai Immunotherapeutics Congratulates its Co-Lead Scientific Research...

Scinai Immunotherapeutics Congratulates its Co-Lead Scientific Research Collaborator Dirk Grlich on Louis-Jeantet Prize

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Scinai Immunotherapeutics CEO issues letter to shareholders

Scinai Immunotherapeutics CEO Issues Letter to Shareholders Scinai Immunotherapeutics CEO Issues Letter to Shareholders PR Newswire JERUSALEM, Jan. 4, 2024 JERUSALEM, Jan. 4, 2024 /PRNewswire...

Scinai Immunotherapeutics CEO Issues Letter to Shareholders

Scinai Immunotherapeutics Announces Closing of Exercise of Outstanding Warrants for $1.69 Million in Gross Proceeds Scinai Immunotherapeutics Announces Closing of Exercise of Outstanding Warrants for...

Scinai Immunotherapeutics Announces Closing of Exercise of Outstanding Warrants for $1.69 Million in Gross Proceeds

Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel.

Watchers	4,717
52-Wk Low	$0.4311
52-Wk High	$2.27

Volume	14,483.00
52-Wk High	$2.27
52-Wk Low	$0.4311

SCNI Scinai Immunotherapeutics Ltd.

About

Feed

News

Fundamentals